Extended abstract deadline for International Pandemic Sciences Conference 2025
20 February 2025
The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2025 has been extended to 23:59 GMT on Wednesday 26 February.
Advances in AI can help prepare the world for the next pandemic
19 February 2025
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
New partnership to advance public health and life science research collaboration in West Africa
13 February 2025
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
Abstract submissions open for International Pandemic Sciences Conference 2025
6 February 2025
Abstract and bursary submissions are now open for the International Pandemic Sciences Conference 2025 – Getting Ahead of the Curve.
Pig research paves way for human respiratory vaccine development
9 January 2025
A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.
Registration now open for International Pandemic Sciences Conference 2025
7 January 2025
Representatives from academia, industry, civil society, and the public sector are invited to register for the International Pandemic Sciences Conference 2025, taking place in Oxford and online from 30 June to 1 July 2025.
Optimising testing for disease surveillance with machine learning
19 December 2024
A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.
Nipah Virus Research Day showcases cross-disciplinary advances
6 December 2024
Over 100 researchers convened for a PSI-hosted event exploring the latest interdisciplinary research to combat this deadly virus.
University of Oxford unveils new vaccine development partnership
15 November 2024
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu
11 November 2024
Increased genomic surveillance capacity allowed a deeper insight into the global distribution patterns of seasonal flu and other respiratory viruses.
Reconstructing a lifetime of flu infections to understand long-term trends
8 November 2024
Using antibody data and mathematical modelling, a new study estimates annual patterns of influenza infection and protection over the past fifty years.
£5.5m funding boost for health protection research on emerging and zoonotic infections
7 November 2024
University of Oxford collaborators from the Pandemic Sciences Institute and the Department of Statistics will keep contributing actively to the new iteration of the Health Protection Research Unit in Emerging and Zoonotic Infections.
Moh Family Foundation visit highlights vital support for pandemic preparedness research
24 October 2024
The Pandemic Sciences Institute welcomed the Moh Family Foundation to Oxford to share latest research updates and celebrate the Foundation’s generous support.
Large-scale study on Long Covid highlights urgent, global need for investment
22 October 2024
A new study in BMJ Global Health reveals the key Long Covid characteristics affecting populations worldwide, including fatigue, shortness of breath and having trouble thinking clearly. 6-12 months after hospital discharge, 70% of study participants were affected by Long Covid in high-income countries, and 42% in low and middle-income countries.
Study suggests possible new transmission route for highly pathogenic avian influenza
17 October 2024
Understanding actual “bird flu” rates in humans will help prevent further spillover and a potential new pandemic.
Study explores aerosol immunisation as path to broadly protective influenza vaccine
16 October 2024
Scientists at PSI and Pirbright have taken a significant step towards developing a universal influenza vaccine.
New multidisciplinary programme to develop digital pandemic tools
27 September 2024
The Oxford Martin Programme on Digital Pandemic Preparedness will be co-led by researchers affiliated with the Pandemic Sciences Institute.
PSI seminar series launches with talk on pandemic control measures
25 September 2024
Leading infectious disease epidemiologist Professor Adam Kucharski presented on opportunities to generate key insights into pandemic pathogens while implementing outbreak control measures, using insights from COVID-19, as part of a new series of pandemic sciences seminars.
Oxford Vaccine Group announces return of science and healthcare podcast
19 September 2024
A brand-new season of The Oxford Colloquy – a podcast series of conversations with leading experts in science and healthcare – is launched this week by Oxford Vaccine Group.
PSI collaborates with Oxford’s History of Science Museum on new exhibition
12 August 2024
The latest exhibition "A Healthy Future for All?" explores the science driving advancements in healthcare